Showing results (41-50 of 403) with videos related to

Sort By:
Pageof 41
Vaccines|June 2, 2021
Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in CancerMargaux Saillard, Mara Cenerenti, Pedro Romero, et al.
Methods in Enzymology|January 18, 2020
Detecting and analyzing murine innate lymphoid cellsAlejandra Gomez-Cadena, Pedro Romero, Sara Trabanelli, et al.
Journal of Diabetes and Its Complications|June 23, 2004
Risk factors for diffuse and focal macular edemaPedro Romero Aroca, Mercè Salvat, Juan Fernández, et al.
Methods in Enzymology|February 1, 2020
Recombinant fusion proteins for targeting dendritic cell subsets in therapeutic cancer vaccineStéphanie Corgnac, Natalia K Botelho, Alena Donda, et al.
Tropical Medicine and Infectious Disease|March 28, 2023
"Does a Respiratory Virus Have an Ecological Niche, and If So, Can It Be Mapped?" Yes and YesChristopher R Stephens, Constantino González-Salazar, Pedro Romero-Martínez
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2018
PD-1 Blockade Unleashes Effector Potential of Both High- and Low-Affinity Tumor-Infiltrating T CellsAmaia Martínez-Usatorre, Alena Donda, Dietmar Zehn, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2008
Selective accumulation of differentiated FOXP3(+) CD4 (+) T cells in metastatic tumor lesions from melanoma patients compared to peripheral bloodCamilla Jandus, Gilles Bioley, Daniel E Speiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Toll-like receptor 3 expressed by melanoma cells as a target for therapy?Bruno Salaun, Serge Lebecque, Sampsa Matikainen, et al.
Lancet (London, England)|February 16, 2008
Tumour immunity: effector response to tumour and role of the microenvironmentAlberto Mantovani, Pedro Romero, A Karolina Palucka, et al.
Pageof 41